The authors would like to extend our appreciation for the Becker Library at Washington University and the resources provided to complete this project.

Alzheimer’s Disease Onset and Progression in International Cohorts (ADOPIC) study Investigator list

Principal Investigators

11Walter Kukull; Departments of Epidemiology University of Washington, Seattle U.S.A.

Colin L Masters; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Melbourne, Australia

John C Morris; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A.

12Michael Weiner; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California, U.S.A.

Biostats, Database and Bioinformatics

13Samantha Burnham; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Melbourne, Australia

14Tim Cox; CSIRO Health and Biosecurity, Brisbane, Australia

15James Doecke; CSIRO Health and Biosecurity, Brisbane, Australia

16Victor Fedyashov; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Melbourne, Australia

Jurgen Fripp; CSIRO Health and Biosecurity, Brisbane, Australia

17Rosita Shishegar; CSIRO Health and Biosecurity, Brisbane, Australia

18Chengjie Xiong; Washington University School of Medicine, Washington University in St. Louis, Missouri

19Daniel Marcus; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A

19Parnesh Raniga; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Melbourne, Australia

20Shenpeng Li; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Melbourne, Australia

Cognition

21Andrew Aschenbrenner; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A

22Jason Hassenstab; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A

23Yen Ying Lim; Turner Institute for Brain and Mental Health, Monash University, Melbourne, Australia

24Paul Maruff; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Melbourne, Australia

25Hamid Sohrabi; The School of Medical Sciences, Edith Cowan University, Joondalup, WA, Australia

26Jo Robertson; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Melbourne, Australia

27Shaun Markovic; Centre for Healthy Ageing, Health Futures Institute, Murdoch University, Perth, Washington, Australia

Imaging

Tammie Benzinger; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A

28Pierrick Bourgeat; CSIRO Health and Biosecurity, Brisbane, Australia

29Vincent Doré; CSIRO Health and Biosecurity, Brisbane, Australia

30Clifford Jack Mayo; Foundation for Medical Education and Research, Rochester, FL, United States

31Parinaz Mussoumzadeh; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A

32Chris Rowe; Department of Molecular Imaging & Therapy, Austin Health, Melbourne, Australia

Duygu Tosun; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California, U.S.A.

33Victor Villemagne; Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, U.S.A

CSF and Blood

34Randy Bateman; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A

35Chris Fowler; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A

36Qiao-Xin Li; The Florey Institute of Neuroscience and Mental Health, Melbourne, VIC, Australia

37Ralph Martins; Faculty of Medicine and Human Health Sciences, Macquarie University, North Ryde, Sydney, Australia

38Suzanne Schindler; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A

39Les Shaw; Department of Pathology and Laboratory Medicine, School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA

Genetics

40Carlos Cruchaga; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A

41Oscar Harari; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A

42Simon Laws; School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia

Andrew Saykin; Department School of Medicine, Indiana University, Bloomington IN, U.S.A

43Tenielle Porter; School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia

44Eleanor O’Brien; School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia

Neuropathology

45Richard Perrin; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A

NACC

11Walter Kukull; Departments of Epidemiology University of Washington, Seattle U.S.A

DIAN

34Randy Bateman; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A

46Eric McDade; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A

John C Morris; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A

Cerebrovascular Disease (CVD) Risk

Tammie Benzinger; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A

30Clifford Jack; Foundation for Medical Education and Research, Rochester, FL, United States

John Morris; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A

47Nawaf Yassi; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Melbourne, Australia

Manu Goyal; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A

Jeremy Strain; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A

Hussain Jafri; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A

Andrei Vlassenko; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A

Kyle Womack; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A

Hippocampal Sclerosis (HS-TDP43) Risk

28Pierrick Bourgeat; CSIRO Health and Biosecurity, Brisbane, Australia

45Richard Perrin; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A

48Blaine Roberts; Emory School of Medicine, Department of Biochemistry, Department of Neurology, Atlanta, GA, U.S.A

33Victor Villemagne; Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, U.S.A

Artificial Intelligence and Machine Learning

16Victor Fedyashov; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Melbourne, Australia

Jurgen Fripp; CSIRO Health and Biosecurity, Brisbane, Australia

Duygu Tosun; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California, U.S.A.

Manu Goyal; Washington University School of Medicine, Washington University in St. Louis, Missouri, U.S.A

48Benjamin Goudey; Computing and Information Systems, The University of Melbourne, Parkville, Victoria, Australia